HOME › Research Insight › Becton, Dickinson and Company and Beckman Coulter, Inc. Command More Than 50% of the Global Flow Cytometry Market
Becton, Dickinson and Company and Beckman Coulter, Inc. Command More Than 50% of the Global Flow Cytometry Market
The global flow cytometrymarket isthe consolidated market with two major players, namely Becton, Dickinson and Company (U.S.) and U.S. based Beckman Coulter, Inc. (a wholly owned subsidiary of Danaher Corporation) occupying more than 50% of the market. BD Biosciences held the leadership position in the global flow cytometry market with a share of 40% in 2012, and is expected to lead the market in the next five years as well. The company has an extensive product portfolio ranging from instruments to accessories, and has a wide distribution network in the field of flow cytometry.
It operates globally through a network of offices in more than 50 countries across the North America, Europe, Asia-Pacific, Eastern Europe, Middle East, and Africa.The companyís wide range of product and service offerings coupled with its wide geographic presence enables it to maintain its leading position in the global flow cytometry market. Furthermore, the company focuses on technological advancements and new product launches as its key business strategies, to ensure its growth in the global flow cytometry market.
Beckman coulter, Inc. (U.S.) ranks second in the flow cytometry market with a market share of 25% in 2012 and is expected to a give stiff competition to Becton, Dickinson and Company in the next five years.This mainly contributed to its wide product portfolio and strong client base in the field of flow cytometry. Beckman Coulterís clients include biotechnology and pharmaceutical companies, universities, medical schools, and research institutions. In order to increase its share in the global flow cytometry market, the company has been concentrating on acquisitions and new product launches as its key business strategies.
New product launches, partnerships, agreements, collaborations, and joint ventures are the key growth strategies adopted by the leading industry participants. Market players adopted these strategies to access new technologies, expand their products and services portfolio, enter into growing markets, and to increase their market shares.In addition totop market players, companies such, eBioscience, Inc. (U.S.),EMD Millipore Corporation (U.S.), Life Technologies Corporation (U.S.), Luminex Corporation (U.S.), andPartec GmbH (Germany) are primarily focused on new product launches to widen their product offerings, and to expand their growth in the global flow cytometrymarket.
Major strategic developments are taking place in the flow cytometry market which exhibits high-growth potential in the near future. Dominant market players such asBecton, Dickinson and Company (U.S.), Beckman Coulter, Inc. (U.S.), eBioscience, Inc. (U.S.), EMD Millipore Corporation (U.S.), and Life Technologies Corporation (U.S.) introduced several flow cytometryinstruments, reagents and consumables, software, and accessories in order to keep pace with the industry trends.
Flow Cytometry Market by Technology (Cell & Bead-based), Products & Services (Reagents, Instruments, Software, & Accessories), Application (Research & Clinical), End User (Commercial Organizations & Diagnostics Laboratories) - Global Forecasts to 2018
North - Dominion Plaza,
17304 Preston Road,
Suite 800, Dallas, TX 75252